Stefan Ewert

City:

Allschwil

Country:

Switzerland

Published Applications:

Last publication date:

2017-07-13

Top Assignees for applications by Stefan Ewert

The entities that hold a legal rights for patent applications filed by inventor Ewert Stefan:

ESBATECH, AN ALCON BIOMEDICAL RESEARCH UNIT LLC. 4 Zurich-Schlieren, Switzerland
Delenex Therapeutics AG 2 Schlieren, Switzerland
UNIVERSITY OF ZURICH 2 Zurich, Switzerland
ESBATech 1 Schlieren, Switzerland
ESBATech, an Alcon Boimedical Research Unit, LLC 1 Schlieren, Switzerland
NOVARTIS AG 1 Basel, Switzerland
ESBATech, an Alcon Biomedical Research Unit LLC 1 , Switzerland
Delenex Therapeutics AG 1 Shlieren, Switzerland
University of Zurich Prorektorat Forschung 1 Zurich, Switzerland

Recent patent applications by Ewert Stefan

Stefan Ewert from Allschwil, CH has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2017-07-13

US20170198040A1

Chemistry; metallurgy

ANTIBODIES TARGETING CD32b AND METHODS OF USE THEREOF

#2 | 2014-06-19

US20140171634A1

Chemistry; metallurgy

Stable and soluble antibodies inhibiting TNF alpha

#3 | 2013-12-26

US20130345292A1

Chemistry; metallurgy

Humanized antibodies against the beta-amyloid peptide

#4 | 2013-07-04

US20130171143A1

Chemistry; metallurgy

Stable and soluble antibodies inhibiting TNFα

#5 | 2012-03-15

US20120064077A1

Chemistry; metallurgy

Stable and soluble antibodies inhibiting TNFα

#6 | 2011-01-27

US20110020220A1

Chemistry; metallurgy

Humanized antibodies against the β-amyloid peptide

#7 | 2010-12-23

US20100322930A1

Human necessities

FIBRONECTIN-BASED BINDING MOLECULES AND THEIR USE

#8 | 2010-05-06

US20100113355A1

Chemistry; metallurgy

NOVEL ANTIBODY MOLECULES AND NUCLEIC ACIDS BINDING TO FUNGAL STRESS PROTEIN HSP90

#9 | 2009-10-22

US20090263382A1

Chemistry; metallurgy

Stable and soluble antibodies inhibiting TNFα

InventorID:

323285 ⎘